BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 1955395)

  • 1. Anthracycline metabolites from Streptomyces violaceus A262. II. New anthracycline epelmycins produced by a blocked mutant strain SU2-730.
    Johdo O; Watanabe Y; Ishikura T; Yoshimoto A; Naganawa H; Sawa T; Takeuchi T
    J Antibiot (Tokyo); 1991 Oct; 44(10):1121-9. PubMed ID: 1955395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anthracycline metabolites from Streptomyces violaceus A262. III. New anthracycline obelmycins produced by a variant strain SE2-2385.
    Johdo O; Watanabe Y; Ishikura T; Yoshimoto A; Naganawa H; Sawa T; Takeuchi T
    J Antibiot (Tokyo); 1991 Oct; 44(10):1130-40. PubMed ID: 1955396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anthracycline metabolites from Streptomyces violaceus A262. I. Isolation of antibiotic-blocked mutants from Streptomyces violaceus A262.
    Johdo O; Ishikura T; Yoshimoto A; Takeuchi T
    J Antibiot (Tokyo); 1991 Oct; 44(10):1110-20. PubMed ID: 1955394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anthracycline metabolites from Streptomyces violaceus A262. IV. New anthracycline yellamycins produced by a variant strain SC-7.
    Johdo O; Tone H; Okamoto R; Yoshimoto A; Naganawa H; Sawa T; Takeuchi T
    J Antibiot (Tokyo); 1991 Oct; 44(10):1155-9. PubMed ID: 1955397
    [No Abstract]   [Full Text] [Related]  

  • 5. Anthracycline metabolites from Streptomyces violaceus A262. V. New anthracycline alldimycin A: a minor component isolated from obelmycin beer.
    Johdo O; Tone H; Okamoto R; Yoshimoto A; Naganawa H; Sawa T; Takeuchi T
    J Antibiot (Tokyo); 1991 Oct; 44(10):1160-4. PubMed ID: 1955398
    [No Abstract]   [Full Text] [Related]  

  • 6. New rhodomycin analogs, SS-288A and SS-288B, produced by a Streptomyces violaceus A262 mutant.
    Saito S; Katsuda Y; Johdo O; Yoshimoto A
    Biosci Biotechnol Biochem; 1995 Jan; 59(1):135-7. PubMed ID: 7765964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production of new anthracycline antibiotics 1-hydroxy-oxaunomycin and 6-deoxyoxaunomycin by limited biosynthetic conversion using a daunorubicin-negative mutant.
    Yoshimoto A; Johdo O; Tone H; Okamoto R; Naganawa H; Sawa T; Takeuchi T
    J Antibiot (Tokyo); 1992 Oct; 45(10):1609-17. PubMed ID: 1473988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production of a new hybrid anthracycline 4-O-methylepelmycin by heterologous expression of dnrK in epelmycin-producing Streptomyces violaceus.
    Miyamoto Y; Ohta S; Johdo O; Nagamatsu Y; Yoshimoto A
    J Antibiot (Tokyo); 2000 Aug; 53(8):828-36. PubMed ID: 11079805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anthracycline metabolites from baumycin-producing Streptomyces sp. D788. II. New anthracycline metabolites produced by a blocked mutant strain RPM-5.
    Yoshimoto A; Fujii S; Johdo O; Kubo K; Nishida H; Okamoto R; Takeuchi T
    J Antibiot (Tokyo); 1993 Jan; 46(1):56-64. PubMed ID: 8436560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intensely potent anthracycline antibiotic oxaunomycin produced by a blocked mutant of the daunorubicin-producing microorganism.
    Yoshimoto A; Fujii S; Johdo O; Kubo K; Ishikura T; Naganawa H; Sawa T; Takeuchi T; Umezawa H
    J Antibiot (Tokyo); 1986 Jul; 39(7):902-9. PubMed ID: 3759649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anthracycline metabolites from baumycin-producing Streptomyces sp. D788. I. Isolation of antibiotic-blocked mutants and their characterization.
    Yoshimoto A; Johdo O; Fujii S; Kubo K; Nishida H; Okamoto R; Takeuchi T
    J Antibiot (Tokyo); 1992 Aug; 45(8):1255-67. PubMed ID: 1399846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation of new anthracyclines 10-O-rhodosaminyl beta-rhodomycinone and beta-isorhodomycinone from mild-acid treated culture of obelmycin-producing Streptomyces violaceus.
    Johdo O; Yoshioka T; Takeuchi T; Yoshimoto A
    J Antibiot (Tokyo); 1997 Jun; 50(6):522-5. PubMed ID: 9268010
    [No Abstract]   [Full Text] [Related]  

  • 13. Demethyl mutactimycins, new anthracycline antibiotics from Nocardia and Streptomyces strains.
    Speitling M; Nattewan P; Yazawa K; Mikami Y; Grün-Wollny I; Ritzau M; Laatsch H; Gräfe U
    J Antibiot (Tokyo); 1998 Aug; 51(8):693-8. PubMed ID: 9766460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New anthracycline glycosides: 4-O-demethyl-11-deoxydoxorubicin and analogues from Streptomyces peucetius var. aureus.
    Cassinelli G; Rivola G; Ruggieri D; Arcamone F; Grein A; Merli S; Spalla C; Casazza AM; Di Marco A; Pratesi G
    J Antibiot (Tokyo); 1982 Feb; 35(2):176-83. PubMed ID: 6951826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New betaclamycin and aclarubicin analogs obtained by prolonged microbial conversion with an aclarubicin-negative mutant.
    Johdo O; Yoshioka T; Naganawa H; Takeuchi T; Yoshimoto A
    J Antibiot (Tokyo); 1996 Jul; 49(7):669-75. PubMed ID: 8784429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Anthracycline antibiotics from genetically modified streptomycetes. The isolation, spectroscopic structural elucidation and biologic effects of beta-rhodomycin I].
    Ihn W; Schlegel B; Fleck WF; Tresselt D; Gutsche W; Sedmera P; Vokoun J
    Pharmazie; 1984 Mar; 39(3):176-80. PubMed ID: 6427794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Respinomycins A1, A2 B, C and D, a novel group of anthracycline antibiotics. I. Taxonomy, fermentation, isolation and biological activities.
    Ubukata M; Osada H; Kudo T; Isono K
    J Antibiot (Tokyo); 1993 Jun; 46(6):936-41. PubMed ID: 8344875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural studies on avidinorubicin, a novel anthracycline with platelet aggregation inhibitory activity.
    Aoki M; Shirai H; Nakayama N; Itezono Y; Mori M; Satoh T; Ohshima S; Watanabe J; Yokose K; Seto H
    J Antibiot (Tokyo); 1991 Jun; 44(6):635-45. PubMed ID: 2071489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anthracycline metabolites from baumycin-producing Streptomyces sp. D788. III. New anthracycline metabolites produced by blocked mutants 4L-660 and YDK-18.
    Yoshimoto A; Johdo O; Nishida H; Okamoto R; Takeuchi T
    J Antibiot (Tokyo); 1993 Nov; 46(11):1758-61. PubMed ID: 8270500
    [No Abstract]   [Full Text] [Related]  

  • 20. A new anthracycline antibiotic, IT-62-B, converts the morphology of ras-transformed cells back to normal: taxonomy, fermentation, isolation, structure elucidation and biological characterization.
    Kawauchi T; Sasaki T; Yoshida K; Matsumoto H; Chen RX; Huang MY; Tsuchiya KS; Otani T
    J Antibiot (Tokyo); 1997 Apr; 50(4):297-303. PubMed ID: 9186553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.